webinar register page

Webinar banner
This webinar is for users with a Zoom account. New to Zoom? Sign up free.
ACP Webinar - Genomics
The ACP is pleased to welcome you to our webinar on Genomics

This session will involve 2 expert-led presentations covering:

1) Germline Cancer Genomics - Dr Terri McVeigh, Consultant Clinical Geneticist, Royal Marsden Hospital
2) Somatic Cancer Genomics - Dr Ellen Copson, CRUK Associate Professor in Medical Oncology, University of Southampton

These will be followed by a demonstration of GeNotes by the GeNotes Oncogenomics Team, in addition to a panel discussion.

Please remember to register with an email address linked to a zoom account.

Apr 20, 2021 06:00 PM in London

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Dr Terri McVeigh
Consultant Clinical Geneticist @Royal Marsden Hospital
Dr Terri McVeigh is a Consultant Clinical Geneticist specializing in Cancer Genetics. She undertook undergraduate medical training, core surgical training and Higher Specialist Training in Clinical Genetics in Ireland. Her specialist training was funded by the Health Research Board/Health Service Executive National Academic SpR Fellowship, with clinical and research fellowships in the Royal Marsden, Yale University, and in Brisbane. She was awarded a PhD from National University of Ireland, Galway for her work investigating the translational applications of genomic profiling in breast cancer. She holds a Masters in Clinical Education. She is a core tutor of the Molecular Pathology of Cancer and Application in Cancer Diagnosis, Screening, and Treatment Module of the ICR -led MSc in Genomic Medicine (Imperial College London). She is a member of the steering committee of the Cancer Genetics Group of the British Society of Genomic Medicine.
Dr Ellen Copson
Associate Professor and Honorary Consultant in Medical Oncology @University of Southampton
Dr Copson trained in London and Southampton and, following a PhD studying the molecular genetics of the BRCA1 gene, has a particular interest in the genomic and modifiable host factors which influence outcomes of early breast cancer. She is Cancer lead of the Wessex Genomic Medical Centre and Chair of the Wessex Molecular Tumour Board. She is particularly interested in host factors which influence the response to systemic treatments for early breast cancer. She has a strong interest in oncology training and is chair of the National Oncogenetics Training Working Party, a member of the RCP Specialist Examination Board and a member of the RCR Clinical Oncology Academic Committee. Dr Copson was a NIHR Breast Cancer Clinical Studies Group (CSG) member from 2013 to 2019 and led the development of a new national Breast Cancer Trainees Research Collaborative Group which she continues to chair.